Recent advancements in molecular imaging, particularly with Positron Emission Tomography (PET) using radiolabelled Prostate‐Specific Membrane Antigen (PSMA) tracers, have shown significant improvements in enhancing prostate cancer detection. Here, FOLH1 is linked to prostate cancer.